Struggle for Access to Glivec 
in South Korea
Solidarity Needed Now!!!


What is Glivec?
US FDA approved Glivec, a drug for the 
treatment of chronic myelogenic leukemia 
(CML), in May 2001. In fact, Glivec is the one 
and only drug that is effective for refractory 
CML patients. But it is still 'not a drug of 
hope, but a drug of despair' in South Korea.